Boston, MA 10/08/2014 (wallstreetpr) – Artificial sapphire glass manufacturer GT Advanced Technologies Inc (NASDAQ:GTAT) is all set to pled its case for bankruptcy protection on 9th October. The case will come up for hearing in front of the U.S. bankruptcy court based in Manchester, New Hampshire. The Wall Street Journal had first reported the news yesterday that the specialized glass maker has taken legal recourse to protect itself. It is said to be having payment issues with a vendor. The investors in the stock of GT Advanced Technologies Inc (NASDAQ:GTAT) had a roller coaster ride yesterday. The stock gained as much as 130 percent over Monday close price during the afternoon session yesterday. It trimmed these gains substantially towards the end of the trading session though. Shares of GT Advanced Technologies Inc (NASDAQ:GTAT) closed up by 51.25% at $1.21.
Real estate services provider IFM Investments Limited (ADR) (NYSE:CTC) which focuses on its customers in China announced that it has signed a strategic partnership agreement with SouFun Holdings Ltd (NYSE:SFUN). SouFun has over the years has emerged as the premier online real estate platform in the Chinese market. The agreement spells out the terms under which the two companies will co-operate with each other to grow their mutual businesses. These areas of collaboration include new emerging revenue generation opportunities in advertising, internet and real estate financing. As part of the tie up Century 21 China would be issuing new shares which would be bought by SouFun. Shares of IFM Investments Limited (ADR) (NYSE:CTC) were up by 49.28% to close at $2.09
IsoRay, Inc. (NYSEMKT:ISR) announced on 7th October that it has generated positive, top of the line results from tests conducted on a suffering female patient who was treated with drug Cesium-131 seed. The drug was administered into the patient via a proprietary “stereotactic implant”. The medical technology firm has indicated that the patient is suffering from an extreme form of glioblastoma brain tumour. The ailment cannot be address surgically via operation. Shares of IsoRay, Inc. (NYSEMKT:ISR) continue to carry the positive momentum as it closed up by 19.57% at $1.65.
